Plan Nacional De Preparación Y Respuesta A La Pandemia De Influenza

Pandemic Preparedness and Response Health Guideline 2009
Paraguay Spanish PDF
National

AI-Generated Document Summary

Objectives

Establish an integrated, action-oriented national preparedness and response framework for influenza pandemics in Paraguay, recognising that a pandemic cannot be prevented but that coordinated preparedness can reduce deaths, illness, suffering, social disruption and economic losses.The plan aligns with World Health Organization pandemic phases and recommendations, spanning the interpandemic, alert, pandemic and recovery periods.

  • Strengthen planning, coordination, surveillance, prevention and containment, health-system response, and social communication as the plan’s five principal components.
  • Improve early detection, laboratory confirmation, notification and investigation of influenza-like illness, severe respiratory infection, unusual clusters and animal outbreaks through integrated human, laboratory and animal surveillance.
  • Contain or delay early transmission to gain time for preparedness measures, including vaccine development and deployment, before sustained person-to-person transmission makes containment unfeasible.
  • Protect population health and essential services through vaccination of priority groups, antiviral access, infection prevention and control, case management, social-distancing measures, continuity planning and equitable allocation of scarce health resources.
  • Reduce risks associated with avian and swine influenza by monitoring animal disease, unusual mortality, production systems and population risk factors, and by coordinating animal and human health responses.
  • Restore services and reorganise operations after the pandemic, maintaining preparedness until a new pandemic phase emerges.

Implementation

Deliver the plan through a phased, multisectoral and decentralised model led by the Ministry of Public Health and Social Welfare, combining national direction with regional and local implementation, referral networks, surveillance systems, emergency coordination and public communication.The National Committee for Response to a Possible Influenza Pandemic coordinates implementation, monitors actions and proposes timely measures, chaired by the Minister of Public Health and Social Welfare with the Vice-Ministry acting as Executive Secretariat.

  • Coordinate technical delivery through the Directorate-General of Health Surveillance, the Technical Operational Group, the Public Health Commission and regional committees, with the National Emergency Secretariat leading phases 5 and 6 alongside health authorities and other sectors.
  • Engage health services, the Ministry of Agriculture and Livestock, the National Service for Animal Quality and Health, social security, municipalities, emergency authorities, laboratories, education, defence, finance, private providers, civil society and international partners.
  • Maintain human surveillance through mandatory notification, sentinel centres, clinical and virological monitoring, mortality surveillance and reporting at points of entry, hospitals and health facilities.Intensify reporting from weekly age-disaggregated notifications in unaffected phases to daily reports and supplementary outbreak forms when the country is affected.
  • Integrate animal-health surveillance through risk assessment, passive and active monitoring, serological studies, movement controls, private veterinary laboratory involvement and reciprocal notification between animal and human health services.
  • Operate the National Influenza Information Centre as an information hub receiving regional data on consultations, admissions, deaths, supplies and basic services, analysing these data and redistributing findings to support corrective action, service planning and assessment of economic impact.
  • Prepare health services at every level with respiratory-isolation areas, infection-control procedures, trained staff, essential medicines and supplies, designated referral hospitals, safe transport, referral and counter-referral arrangements, surge capacity and daily inventories of beds, supplies and workforce availability.
  • Implement containment measures proportionately to the epidemiological phase, including case isolation, contact tracing, quarantine support, entry-point surveillance, school closures, cancellation of mass gatherings, travel measures and strategic antiviral use.
  • Apply clinical protocols for triage, notification, laboratory sampling, referral, treatment, home isolation and follow-up of contacts, with strict airborne, droplet, contact and standard precautions for suspected or confirmed cases.
  • Protect health workers and patients through vaccination, antiviral prophylaxis where indicated, twice-daily temperature monitoring after exposure, personal protective equipment, hand hygiene, respiratory hygiene, environmental cleaning, safe laundry processing and infectious-waste management.
  • Use a segmented risk-communication strategy to provide transparent, timely and consistent information, prepare spokespersons, engage communities and promote preventive behaviours such as reporting sick birds, handwashing, respiratory hygiene and timely care-seeking.
  • Review and update plans, protocols and response measures as epidemiological scenarios and scientific evidence change; use simulation exercises, preparedness assessments and phase-specific monitoring to identify capacity gaps and adjust interventions.
  • Mobilise resources through national budgetary reserves, financial reserve funds and additional-resource procedures for vaccines, antivirals, laboratory inputs and other preventive measures, although no total budget, funding allocation or quantified financing gap is specified.

Monitoring & Evaluation

The plan establishes a comprehensive, phase-based monitoring and evaluation system centred on integrated human, laboratory and animal surveillance; rapid notification and investigation; health-service capacity monitoring; and coordinated national, regional and international information exchange.

  • Strengthen human influenza surveillance through clinical and virological monitoring of influenza-like illness, severe acute respiratory infection, hospital admissions, influenza-related mortality and circulating virus types.
  • Integrate animal surveillance for avian and swine influenza with human surveillance, including risk assessment, monitoring of unusual bird and pig mortality, serological studies, investigation of outbreaks, movement controls and notification between animal-health and public-health authorities.
  • Use mandatory case notification, sentinel surveillance, laboratory confirmation, mortality surveillance and outpatient information to assess morbidity, virus circulation and disease impact.
  • Require weekly age-disaggregated influenza reporting in phases 1 and 2 when Paraguay is unaffected, and daily notification with supplementary forms during outbreaks or pandemic conditions.
  • Report epidemic outbreaks daily by probable cases and clusters, submit weekly service-activity forms, and disseminate findings through weekly reports, technical reports, bulletins and web-based information.
  • Issue epidemiological alerts across Sanitary Regions after Phase 5, notify suspected or probable cases immediately, submit field-investigation reports within 24 hours, and complete hospital investigations immediately and within 24 hours of case detection.
  • Monitor contacts daily for symptoms, follow contacts for 10 days where required, and require immediate notification of symptomatic contacts.
  • Monitor health-worker exposure through twice-daily temperature checks, febrile-event reporting, clinical assessment and suspension from direct care when fever develops.
  • Use simplified pandemic surveillance during Phase 6, including daily reporting of cases by health region and age group, antiviral-resistance monitoring, prioritised laboratory sampling and genomic analysis of severe cases.
  • Maintain surveillance at airports, ports and land borders, including rapid detection, notification, isolation, specimen collection and referral of suspected cases among travellers and transport personnel.
  • Maintain laboratory capacity through trained staff, reagents, equipment, border laboratories, reference-laboratory strengthening, virus characterisation and sharing of isolates with international influenza laboratories.
  • Monitor health-system readiness through daily facility inventories of beds, oxygen-equipped beds, intensive-care beds, supplies and human resources; update hospital and ambulatory indicators every six months; and track occupancy and average length of stay.
  • Use the National Influenza Information Centre to receive, analyse and redistribute regional data on admissions, consultations, deaths, supplies and basic services, supporting corrective action, service planning and assessment of epidemic economic impact.
  • Assign the National Committee responsibility for monitoring implementation, evaluating planning activities and coordinating information for national and international bodies, supported by the Operational Group, Technical Coordination Group and Public Health Commission.
  • Review the national plan continuously during alert and pandemic phases using epidemiological evidence and World Health Organization recommendations; review regional arrangements and phase-specific measures as the situation changes.
  • Evaluate preparedness using the World Health Organization checklist, assess health-system outbreak detection and containment capacity, supervise containment actions, and evaluate treatment, infection-control and prophylaxis measures for adjustment.
  • Conduct communication evaluation through baseline and follow-up research on public knowledge, attitudes, practices, perceptions, information sources and behavioural responses.

The plan provides multiple operational reporting frequencies, surveillance activities and governance responsibilities, but does not specify a single consolidated indicator framework, numerical performance targets, unified evaluation methodology, independent audit process or sanctions-based accountability system.

Costing & Financing

The plan recognises that pandemic preparedness requires sustained financing, reserve resources, strategic supplies and capacity expansion, but does not provide a costed budget, funding totals, funding sources, allocations, quantified gaps or economic assumptions.

  • Secure financing for development, long-term sustainability and periodic updating of the national pandemic plan.
  • Create a national budgetary reserve for pandemic preparedness during Phase 1.
  • Seek additional resources and guarantee financial reserve funds for vaccines, antiviral medicines and other preventive measures.
  • Develop financial and logistical plans to ensure medical and non-medical supplies for pandemic care, including medicines, personal protective equipment, laboratory materials and storage arrangements.
  • Track available national and international resources, identify extraordinary resources needed during a pandemic, and mobilise resources across public, private, social-security, military and other health-system providers.
  • Maintain strategic reserves and distribution arrangements for medical supplies, medicines, equipment, vaccines, antivirals and additional beds as demand escalates.
  • Assess and value capacity gaps in human resources, equipment, supplies, medicines, antivirals, antibiotics, antiretrovirals and protective equipment for ambulatory and hospital care.
  • Procure and maintain laboratory supplies, reagents and equipment, while ensuring staffing, training and diagnostic capability for surveillance and outbreak response.
  • Prioritise vaccination for at-risk groups and essential personnel, maintain antiviral availability and storage, and secure infection-control materials and personal protective equipment.
  • Assess resource availability when selecting public-health measures and reconsider interventions with low expected impact or limited practicality.

The plan identifies economic losses from seasonal influenza, the social and economic consequences of a pandemic, and financial barriers faced by border populations seeking specialised care.Vaccination for vulnerable populations is identified as a cost-effective preventive measure, while international traveller-entry research is described as costly and of limited impact on international pandemic spread.

Resource requirements include health-service surge capacity, isolation facilities, hospital beds, intensive-care equipment, ambulance biosafety materials, communications systems, workforce deployment, laboratory testing, animal surveillance, quarantine support and continuity of essential services, but no monetary values are supplied for these requirements.

Document Viewer